← Back
Data updated: Mar 29, 2026
INGENUS PHARMS LLC
CardiovascularOphthalmologyNeurology
Generics
INGENUS PHARMS LLC is a generic drug manufacturer focused on Cardiovascular, Ophthalmology, Neurology.
1996
Since
37
Drugs
-
Trials
321
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
ARSENIC TRIOXIDE 2026-01-30
Labeling
MESNA 2026-01-27
CARBAMAZEPINE 2026-01-05
Labeling
TIZANIDINE HYDROCHLORIDE 2025-12-16
Labeling
CABERGOLINE 2025-12-11
Labeling
LEVETIRACETAM 2025-12-02
TIZANIDINE HYDROCHLORIDE 2025-11-25
Labeling
LEVETIRACETAM 2025-11-21
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 46%
6 drugs
Ophthalmology 15%
2 drugs
Neurology 15%
2 drugs
Infectious Disease 15%
2 drugs
Immunology 8%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
AbbVie big-pharma
Immunology, Neurology, Infectious Disease, Ophthalmology
Novartis big-pharma
Cardiovascular, Immunology, Ophthalmology
BAUSCH AND LOMB specialty
Ophthalmology, Cardiovascular, Infectious Disease, Immunology
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
Baxter specialty
Infectious Disease, Cardiovascular, Ophthalmology
Active (22)
DEHYDRATED ALCOHOL BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE IVABRADINE HYDROCHLORIDE TAFLUPROST PRIMAQUINE PHOSPHATE CLONIDINE LEVETIRACETAM DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PANTOPRAZOLE SODIUM METHENAMINE HIPPURATE NORETHINDRONE ACETATE MESNA DICLOFENAC POTASSIUM MEXILETINE HYDROCHLORIDE TRIAZOLAM TIMOLOL MALEATE CLINDAMYCIN PHOSPHATE DESIPRAMINE HYDROCHLORIDE CARBAMAZEPINE BUTALBITAL, ACETAMINOPHEN AND CAFFEINE AMPHETAMINE SULFATE
Discontinued (15)
Company Info
- First Approval
- 1996-09-27
- Latest
- 2025-12-11
- Applications
- 37